Coenzyme Q10 treatment of congestive heart failure: Results of meta-analyses of controlled clinical trials;Behandling af kronisk hjerteinsufficiens med conezym Q10 belyst ved metaanalyser af klinisk kontrollerede undersogelser

Ugeskrift for Laeger

Volumn 159, Issue 49, 1997, Pages 7302-7308

  Soja, Anne Merete ^a   Mortensen, Svend Aage ^a  

^a NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

UBIDECARENONE;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFICACY; HEART EJECTION FRACTION; HEART INDEX; HEART LEFT VENTRICLE EJECTION TIME; HEART OUTPUT; HEART STROKE VOLUME; HUMAN; INOTROPISM; META ANALYSIS; MULTICENTER STUDY; REVIEW;

ANTIOXIDANTS; CLINICAL TRIALS; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; META-ANALYSIS; UBIQUINONE;

EID: 0031446675     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Crane FL. Physiological coenzyme Q function and pharmacological reactions. I: . Folkers K, Yamamura Y, eds. Biomedical and clinical objects of Coenzyme Q. Amsterdam: Elsevier Science Publishers, 1986; 5: 3-14.
2. Beyer RE. The participation of coenzyme Q in free radical production and antioxidation. Free Radic Biol Med 1990; 8: 545-65
3. Karlsson J, Diamant B, Theorell H, Folkers K. Ubiquinone and -tocopherol in plasma; means of translocation or depot Clin Invest 1993; 71: 84-91.
4. Lin L, Sotonyi P, Somogyi E, Karlsson J, Folkers K, Nara Y et al. Coenzyme Q10 content in different parts of the normal human heart. Clin Physiol 1988; 8: 391-8.
5. Mortensen SA. Endomyocardial biopsy. Technical aspects and indications [disp.]. København: Lægeforeningens forlag, 1989: 3-36.
6. Folkers K, Vadhanavikit S, Mortensen SA. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with CoQ10. Proc Nth Acad Sci USA 1985; 82: 901-4.
7. Folkers K, Littarru GP, Ho L, Runge MT, Havanonda S, Cooley D. Evidence for a deficiency of coenzyme Q10 in human heart disease. Int J Vitam Nutr Res 1970; 40: 380-90.
8. Kitamura N, Yamaguchi A, Otaki M, Sawatani O, Minoji T, Tamura H et al. Myocardial tissue level of coenzyme Q10 in patients with cardiac failure. I: Folkers K, Yamamura Y, eds. Biomedical and clinical aspects of coenzyme Q. Amsterdam: Elsevier Science Publishers. 1984; 4: 243-52.
9. Mortensen SA. Perspectives on therapy of cardiovascular diseases with coenzyme Q10 (Ubiquinone). Clin Invest 1993; 71: 116-23.
10. Littarru GP, Ho L, Folkers K Deficiency of coenzyme Q10 in human heart disease. Part I & II. Int J Vitam Nutr Res 1972; 42: 294-305 og 413-34.
11. Sehested T, Heidt P, Hetzer R. Normal levels of coenzyme Q10 in patients awaiting cardiac transplantation. Transplant Proc 1993, 25: 2365-7.
12. Mortensen SA, Aabo K, Jonsson T, Baandrup U. Clinical and non-invasive assessment of anthracycline cardiotoxicity: perspectives on myocardial protection. Int J Clin Pharmacol Res 1986; 6: 137-50.
13. Wilms K, Ehninger G. Clinical significance of the toxicity of adriamycin. I: Folkers K, Yamamura Y, eds Biomedical and clinical aspects of coenzyme Q. Amsterdam: Elsevier/North-Holland Biomedical Press, 1981; 3: 129-36.
14. Nohl H, Jordan W, Youngman RJ. Quinones in biology: functions in electron transfer end oxygen activation. Free Radic Biol Med 1986; 2: 211-79.
15. Solaini G, Ronca G, Bertelli A. Inhibitory effects of several anthracyclines on mitochondrial respiration and coenzyme Q10 protection. Drugs Exp Clin Res 1985; 11: 533-7.
16. Judy WV, Hall JM, Dugan W, Toth PD, Folkers K. Coenzym Q10 reduction of adriamycin cardiotoxicity. I: Folkers K, Yamamura Y, eds. Biomedical and clinical aspects of coenzyme Q. Amsterdam: Elsevier Science Publishers, 1984; 4: 231-40.
17. Mortensen SA, Vadhanavikit S, Muratsu K, Folkers K. Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure. Int J Tissue React 1990; 12: 155-62
18. Ernster L, Forsmark-Andreé P. Ubiquinol: an endogenous antioxidant in aerobic organisms. Clin Invest 1993; 71. 60-5.
19. Lenaz G. A biochemical rationale for the therapeutic effects of CoQ. I: Lenaz G, ed. Coenzyme Q. Chichester. John Wiley & Son, 1985: 20: 435-40.
20. Rengo F, Abete P, Landino P, Leosco D, Covelluzzi F, Vitale D et al. Role of metabolic therapy in cardiovascular disease. Clin Invest 1993; 71: 124-8.
21. Folkers K, Watanabe T, Kaji M. J. Critique of coenzyme Q in biochemical and biomedical research and in ten years of clinical research on cardiovascular diseases. J Mol Med 1977; 2: 431-60.
22. Langsjoen PH, Vadhanavikit S, Folkers K. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and cross over trial with coenzyme Q10. Proc Natl Acad Sci USA 1985; 82: 4240-4.
23. Judy WV, Hall JH, Toth PD, Folkers K Double blind double cross over study of coenzyme Q10 in heart failure. I: Folkers K, Yamamura Y, eds. Biomedical and clinical aspects of coenzyme Q. Amsterdam: Elsevier Science Publishers, 1986; 5: 315-23.
24. Schneeberger W, Muller-Steinwachs J, Anda LP, Fuchs W, Zilliken F, Lyson K et al. A clinical double blind and cross over trial with coenzym Q10 on patients with cardiac disease. I: Folkers K, Yamamura Y, eds. Biomedical and clinical aspects of coenzyme Q. Amsterdam: Elsevier Science Publishers, 1986; 5: 325-33.
25. Rossi E, Lombardo A, Testa M, Lippa S, Oradei A, Littarru GP et al. Coenzyme Q10 in ischemic cardiopathy. I: Folkers K, Littarru GP, Yamagami T, eds. Biomedical and clinical aspects of coenzyme Q. Amsterdam: Elsevier Science Publishers, 1991; 6: 321-6.
26. Serra G, Ussoni F, Piemonti C, Mazzola C. Evaluation of coenzyme Q10 in patients with moderate heart failure and chronic stable effort angina. I: Folkers K, Littarru G P, Yamagami T, eds. Biomedical and clinical aspects of coenzyme Q. Amsterdam: Elsevier Science Publishers, 1991; 6: 327-38
27. Swedberg K, Hoffman-Bang C, Rehnqvist N, Åstrøm H for the Q10. Study Group. Coenzyme Q10 as an adjunctive in the treatment of congestive heart failure. J Cardiac Failure 1995; 1: 101-7.
28. Langsjoen PH, Vadhanavikit S, Folkers K. Effective treatment with coenzyme Q10 of patients with chronic myocardial disease. Drugs Exp Clin Res 1985; 11: 577-9.
29. Permanetter B, Rossy W, Klein G, Weingartner F, Seidl KF, Blomer H Ubiquinone (coenzyme Q10) in the long-term treatment of idiopatic dilated cardiomyopathic. Eur Heart J 1992; 13: 1528-33.
30. Monaco C, Trimarco B, Condorelli M. Effects of coenzyme Q10 therapy in patients with congestive heart failure: a long term multicenter randomized study. Clin Invest 1993; 71: 134-6.
31. Pogessi L, Galanti G, Comeglio M, Toncelli L, Vinci M. Effect of coenzyme Q10 on left ventricular function in patients with dilative cardiomyopathy. Curr Ther Res 1991; 49: 878-86.
32. Morisco C, Nappi A, Argenziano L, Sarno D, Fonatana D, Imbriaco M et al. Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure. Effects of short-term coenzyme Q10 treatment Mol Aspects Med 1994; 15: 155-63.
33. Judy WV, Folkers K, Hall JH. Improved long-term survival in coenzyme Q10 treated chronic heart failure patients compared to conventionally treated patients. I. Folkers K, Littarru GP, Yamagami T, eds. Biomedical and clinical aspects of coenzyme Q. Amsterdam: Elsevier Science Publishers, 1991; 6: 291-8.
34. Vanfraechem JPH, Picalausa C, Folkers K. Effects of CoQ10 on physical performance and recovery in myocardial failure. I: Folkers K, Yamamura Y, eds. Biomedical and clinical aspects of coenzyme Q. Amsterdam: Elsevier Science Publishers, 1986; 5: 371-7.
35. Muller-Steinwachs J, Anda LP, Zilliken F. Eine klinische Doppelblind Studie mit Coenzym Q10 und Vitamin E bei herzkranken Patienten. Orthomolecul Koerier 1990; 5: 4-11.
36. Sacks HS, Berrier J, Reitman D, Ancona-Beck VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med 1987; 316. 450-5.
37. Draborg EU. Meta-analyse, en kvantitativ aggregeringsmetode. Et arbejdsnotat. Odense: Center for Helsetjenesteforskning og Socialpolitik. CHS, 1994: 1.
38. Hedges LVJ. Distribution theory for Glass's estimator of effect size and related estimators. Educ Stat 1981; 6: 107-28.